ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
4.420
-0.170 (-3.70%)
At close: Oct 10, 2025, 4:00 PM EDT
4.310
-0.110 (-2.49%)
After-hours: Oct 10, 2025, 7:49 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $497.25 million as of October 10, 2025. Its market cap has increased by 68.07% in one year.
Market Cap
497.25M
Enterprise Value
683.45M
1-Year Change
68.07%
Ranking
Category
Stock Price
$4.42
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $497.25M, a decrease of -75.66%. That is a compound annual growth rate of -22.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 497.25M | 158.43% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 767.88B |
| Johnson & Johnson | 460.19B |
| AbbVie | 407.53B |
| UnitedHealth Group | 333.01B |
| AstraZeneca | 266.87B |
| Novo Nordisk | 261.06B |
| Novartis AG | 256.06B |
| Abbott Laboratories | 232.02B |